ProQR Therapeutics Stock (NASDAQ: PRQR)
|Day Range0.74 - 0.79||52 Wk Range0.53 - 8.6||Open / Close0.76 / 0.74||Float / Outstanding67.1M / 71.4M|
|Vol / Avg.240.6K / 390.4K||Mkt Cap53.1M||P/E-||50d Avg. Price0.8|
|Div / Yield-||Payout Ratio-||Total Float67.1M||EPS-0.21|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
There are no as such competitors for ProQR Therapeutics.
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by HC Wainwright & Co. on Monday, August 15, 2022. The analyst firm set a price target for 1.50 expecting PRQR to rise to within 12 months (a possible 101.61% upside). 12 analyst firms have reported ratings in the last year.
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $0.744 last updated Today at September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for ProQR Therapeutics.
ProQR Therapeutics’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for ProQR Therapeutics.
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.